Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction

AB Federici, SD Berkowitz, TS Zimmerman, PM Mannucci

Blood (1992) 79 (1): 38–44.

https://doi.org/10.1182/blood.V79.1.38.38

Published: 1992

Journal Articles

Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine

PA Foster, CA Fulcher, RA Houghten, TS Zimmerman

Blood (1990) 75 (10): 1999–2004.

https://doi.org/10.1182/blood.V75.10.1999.1999

Published: 1990

Journal Articles

Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand disease

SD Berkowitz, H Nozaki, K Titani, T Murachi, EF Plow, TS Zimmerman

Blood (1988) 72 (2): 721–727.

https://doi.org/10.1182/blood.V72.2.721.721

Published: 1988

Journal Articles

von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers

PM Mannucci, R Lombardi, G Castaman, JA Dent, A Lattuada, F Rodeghiero, TS Zimmerman

Blood (1988) 71 (1): 65–70.

https://doi.org/10.1182/blood.V71.1.65.65

Published: 1988

Journal Articles

The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728

Y Fujimura, LZ Holland, ZM Ruggeri, TS Zimmerman

Blood (1987) 70 (4): 985–988.

https://doi.org/10.1182/blood.V70.4.985.985

Published: 1987

Journal Articles

von Willebrand factor and von Willebrand disease [published erratum appears in Blood 1988 Mar;71(3):830]

ZM Ruggeri, TS Zimmerman

Blood (1987) 70 (4): 895–904.

https://doi.org/10.1182/blood.V70.4.895.895

Published: 1987

Journal Articles

Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals

J Batlle, MF Lopez-Fernandez, A Lopez-Borrasca, C Lopez-Berges, JA Dent, SD Berkowitz, ZM Ruggeri, TS Zimmerman

Blood (1987) 70 (1): 173–176.

https://doi.org/10.1182/blood.V70.1.173.173

Published: 1987

Journal Articles

FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting

CA Fulcher, S de Graaf Mahoney, TS Zimmerman

Blood (1987) 69 (5): 1475–1480.

https://doi.org/10.1182/blood.V69.5.1475.1475

Published: 1987

Journal Articles

Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome

U Budde, JA Dent, SD Berkowitz, ZM Ruggeri, TS Zimmerman

Blood (1986) 68 (6): 1213–1217.

https://doi.org/10.1182/blood.V68.6.1213.1213

Published: 1986

Journal Articles

A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF)

PM Mannucci, R Lombardi, AB Federici, JA Dent, TS Zimmerman, ZM Ruggeri

Blood (1986) 68 (1): 269–274.

https://doi.org/10.1182/blood.V68.1.269.269

Published: 1986

Journal Articles

High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC)

G Ciavarella, N Ciavarella, S Antoncecchi, D De Mattia, P Ranieri, J Dent, TS Zimmerman, ZM Ruggeri

Blood (1985) 66 (6): 1423–1429.

https://doi.org/10.1182/blood.V66.6.1423.1423

Published: 1985

Journal Articles

Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation

HI Saba, SR Saba, J Dent, ZM Ruggeri, TS Zimmerman

Blood (1985) 66 (2): 282–286.

https://doi.org/10.1182/blood.V66.2.282.282

Published: 1985

Journal Articles

Ultrastructural localization of human platelet thrombospondin, fibrinogen, fibronectin, and von Willebrand factor in frozen thin section

JD Wencel-Drake, RG Painter, TS Zimmerman, MH Ginsberg

Blood (1985) 65 (4): 929–938.

https://doi.org/10.1182/blood.V65.4.929.929

Published: 1985

Journal Articles

Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion

VT Turitto, HJ Weiss, TS Zimmerman, II Sussman

Blood (1985) 65 (4): 823–831.

https://doi.org/10.1182/blood.V65.4.823.823

Published: 1985

Journal Articles

Further characterization of platelet-type von Willebrand's disease in Japan

H Takahashi, M Handa, K Watanabe, Y Ando, R Nagayama, A Hattori, A Shibata, AB Federici, ZM Ruggeri, TS Zimmerman

Blood (1984) 64 (6): 1254–1262.

https://doi.org/10.1182/blood.V64.6.1254.1254

Published: 1984

Journal Articles

Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V

CA Fulcher, JE Gardiner, JH Griffin, TS Zimmerman

Blood (1984) 63 (2): 486–489.

https://doi.org/10.1182/blood.V63.2.486.486

Published: 1984

Journal Articles

Apparent molecular weight of purified human factor VIII procoagulant protein compared with purified and plasma factor VIII procoagulant protein antigen

MJ Weinstein, CA Fulcher, LE Chute, TS Zimmerman

Blood (1983) 62 (5): 1114–1117.

https://doi.org/10.1182/blood.V62.5.1114.1114

Published: 1983

Journal Articles

Thrombin proteolysis of purified factor viii procoagulant protein: correlation of activation with generation of a specific polypeptide

CA Fulcher, JR Roberts, TS Zimmerman

Blood (1983) 61 (4): 807–811.

https://doi.org/10.1182/blood.V61.4.807.807

Published: 1983

Journal Articles

Isoelectric focusing of human von Willebrand factor in urea-agarose gels

CA Fulcher, ZM Ruggeri, TS Zimmerman

Blood (1983) 61 (2): 304–310.

https://doi.org/10.1182/blood.V61.2.304.304

Published: 1983

Journal Articles

Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor

ZM Ruggeri, R Lombardi, L Gatti, R Bader, C Valsecchi, TS Zimmerman

Blood (1982) 60 (6): 1453–1456.

https://doi.org/10.1182/blood.V60.6.1453.1453

Published: 1982

NARROW

Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction

Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine

Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand disease

von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers

The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728

von Willebrand factor and von Willebrand disease [published erratum appears in Blood 1988 Mar;71(3):830]

Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals

FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting

Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome

A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF)

High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC)

Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation

Ultrastructural localization of human platelet thrombospondin, fibrinogen, fibronectin, and von Willebrand factor in frozen thin section

Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion

Further characterization of platelet-type von Willebrand's disease in Japan

Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V

Apparent molecular weight of purified human factor VIII procoagulant protein compared with purified and plasma factor VIII procoagulant protein antigen

Thrombin proteolysis of purified factor viii procoagulant protein: correlation of activation with generation of a specific polypeptide

Isoelectric focusing of human von Willebrand factor in urea-agarose gels

Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only